SHL Telemedicine Collaborative Trials' Results For SmartHeart Technology To Be Announced At VPM 2023
Portfolio Pulse from Benzinga Newsdesk
SHL Telemedicine is set to announce the results of its collaborative trials for SmartHeart technology at VPM 2023.
September 11, 2023 | 6:23 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
The announcement of the trial results for SHL Telemedicine's SmartHeart technology could potentially impact the company's stock.
The announcement of the trial results for SHL Telemedicine's SmartHeart technology could potentially impact the company's stock. The impact will depend on whether the results are positive or negative, and how the market perceives this news.
CONFIDENCE 70
IMPORTANCE 80
RELEVANCE 100